RT

RTW Biotech Opportunities Ltd

Overview

Corporate Details

ISIN(s):
GG00BKTRRM22
LEI:
549300Q7EXQQH6KF7Z84
Country:
United States of America
Address:
40 10TH AVE, 10014 NEW YORK
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

No description available.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for RTW Biotech Opportunities Ltd. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-22 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB
2025-08-19 08:01
Report Publication Announcement
Notice of Interim Results
English 13.6 KB
2025-08-19 08:00
Capital/Financing Update
Strategic Funding Agreement with Aquestive
English 15.0 KB
2025-08-15 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB
2025-08-14 08:00
Fund Information / Factsheet
Monthly Valuation Update and Factsheet
English 29.3 KB
2025-07-17 08:00
Regulatory News Service
Update on Kailera Therapeutics
English 15.4 KB
2025-07-15 08:00
Fund Information / Factsheet
Monthly Valuation Update and Factsheet
English 32.5 KB
2025-07-10 08:00
M&A Activity
Merck to acquire Verona Pharma
English 15.7 KB
2025-07-03 18:34
Major Shareholding Notification
Holding(s) in Company
English 51.0 KB
2025-03-31 08:00
Annual Report
Annual Financial Report
English 1.6 MB
2025-03-28 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB
2025-03-26 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB

Automate Your Workflow. Get a real-time feed of all RTW Biotech Opportunities Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for RTW Biotech Opportunities Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Adocia Logo
Developing novel drug formulations for metabolic diseases like diabetes and obesity for out-licensing.
France ADOC
Aladdin Healthcare Technologies SE Logo
Develops AI for drug discovery and diagnostics targeting age-related diseases.
Germany NMI
Alligator Bioscience Logo
Develops immuno-oncology antibody drugs for cancer, with a lead candidate for pancreatic cancer.
Sweden ATORX
Alten Logo
Global engineering and IT consulting for digital transformation in industry and telecom sectors.
France ATE
AlzeCure Pharma Logo
Clinical-stage pharma developing drugs for CNS diseases like Alzheimer's and pain.
Sweden ALZCUR
Alzinova AB Logo
Develops immunotherapies and vaccines to treat and prevent Alzheimer's disease.
Sweden ALZ
Amoéba Logo
Develops amoeba-based natural fungicides for agriculture and active ingredients for cosmetics.
France ALMIB
Annexin Pharmaceuticals AB Logo
Clinical-stage biotech developing Annexin A5 protein therapies for ophthalmology and oncology.
Sweden ANNX
Aptahem AB Logo
Develops RNA-based aptamer drugs for acute, life-threatening conditions like sepsis.
Sweden APTA
APTAMER GROUP PLC Logo
Develops custom aptamer-based binders as antibody alternatives for life science applications.
United Kingdom APTA